← All companies
1910
ActiveMultimodal AI Platform for Modality Agnostic Drug Discovery™
Winter 2019Founded 201820 peopleBoston, MA, USA
About
We are the only AI-native biotech pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery.
Founders · 1
Formerly “1910 Genetics”
Related startups
Known MedicineSummer 2020
Combining 3D cell culture & AI to translate drugs to clinical success
Acquired
GEn1E LifesciencesSummer 2019
AI platform accelerating therapies for rare & inflammatory diseases.
Active
